In August, OCRA hosted a listening session with the U.S. Food and Drug Administration (FDA) to better understand the impact of Covid-19 on clinical trial participation.
Watch the full FDA listening session in the video below.
Related Topics
The Overview: August 2025
September is Ovarian and Gynecologic Cancer Awareness Month — a time for our community to unite, raise awareness, and push forward in the search for better treatments and cures. As … Continued
September is Ovarian and Gynecologic Cancer Awareness Month
Join us to make a difference this September! September is our time to spread the word about ovarian cancer risk and prevention, rally for more scientific research, and make progress … Continued
OCRA’s Advocate’s Corner: August 2025
By Chad Ramsey, Vice President, Policy, Ovarian Cancer Research Alliance FY 2026 Appropriations & Congressional Recess: A Vital Advocacy Window As Congress continues its August recess, this “district and state … Continued